Safety Data Sheet
according to Regulation (EC) No. 453/2010
Calcium Chloride 35%, aqueous solution
SECTION 1: Identification of the substance/mixture and of the company/undertaking
1.1.
Product identifier
Product form
: Substance
Trade name
: Calciumchloride 35%, aqueous solution
Chemical name
: Calcium chloride
IUPAC name
: Calcium dichloride
EC index no
: 017-013-00-2
EC no
: 233-140-8
CAS No.
: 10043-52-4
REACH registration No.
: 01-2119494219-28
Formula
: CaCl2
Synonyms
: Calcium chloride, 35%,liquid; Liquid calcium chloride, 35%, aqueous solution
EC-FERTILISER
: D.2
1.2.
Relevant identified uses of the substance or mixture and uses advised against
1.2.1.
Relevant identified uses
Use of the substance/preparation
: The most common uses:dust suppression, road de-icing, food industry: additive,
process aid during oil drilling, cooling media, cement: additive, desiccant,
component of mixed fertilisers
Title
Sector of use
Product
category
Handling of (aqueous)
Calcium Chloride
solutionsX
SU3, SU22
Process category
Article
category
PROC1, PROC2, PROC3,
PROC4, PROC5, PROC6,
PROC7, PROC8a, PROC8b,
PROC9, PROC10, PROC11,
PROC13, PROC14, PROC15
(ES Ref.: Nr. 8)
Environmental
release
ERC1, ERC2,
ERC4, ERC6a,
ERC8a, ERC8d
SPERC
Full text of use descriptors: see section 16.
Remark relevant uses
1.2.2.
: Consult also the relevent exposurescenario in the appendix
Uses advised against
No additional information available
1.3.
Details of the supplier of the safety data sheet
Van Iperen International BV
Smidsweg 24
3273 LK Westmaas - Netherlands
T +31 (0) 186 578 888 - F +31 (0) 186 573 452
[email protected] - www.vaniperen.com
1.4.
Emergency telephone number
Country
Ireland (Republic of)
United Kingdom
Official advisory body
National Poisons Information Centre
Beaumont Hospital
Beaumont Hospital Beaumont
Road
9 Dublin
Guy's & St Thomas' Poisons Unit
Avonley Road
SE14 5ER London
Medical Toxicology Unit, Guy's & St Thomas' Hospital Trust
Version: 4.0
Address
Emergency number
: +353 1 8379964
0870 243 2241
Revision date: 09-02-2012
page 1 from 12
Safety Data Sheet
according to Regulation (EC) No. 453/2010
Calcium Chloride 35%, aqueous solution
SECTION 2: Hazards identification
2.1.
Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP]
Eye Irrit. 2 H319
Full text of H-phrases: see section 16
Classification according to Directive 67/548/EEC or 1999/45/EC
Xi; R36
Full text of R-phrases: see section 16
Adverse physicochemical, human health and environmental effects
No additional information available
2.2.
Label elements
Labelling according to Regulation (EC) No. 1272/2008 [CLP]
Hazard pictograms (CLP)
:
CLP Signal word
: Warning
GHS07
Hazard statements (CLP)
: H319 - Causes serious eye irritation
Precautionary statements (CLP)
: P264 – Wash hands thoroughly after handling.
P280 - Wear protective gloves, protective clothing, eye protection.
P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing
P337+P313 - If eye irritation persists: Get medical advice/attention
2.3.
Other hazards
Other hazards not contributing to the
classification
: The product can cause minor skin irritation and dry skin.
SECTION 3: Composition/information on ingredients
3.1.
Substances
Substance type
: Mono-constituent
Name
Product identifier
%
Classification according to
Directive 67/548/EEC
Calciumchloride vloeibaar 35%
(CAS No.) 10043-52-4
(EC no) 233-140-8
(EC index no) 017-013-00-2
(REACH-no) 01-2119494219-28
35
Xi; R36
Name
Product identifier
%
Classification according to
Regulation (EC) No.
1272/2008 [CLP]
Calciumchloride vloeibaar 35%
(CAS No.) 10043-52-4
(EC no) 233-140-8
(EC index no) 017-013-00-2
(REACH-no) 01-2119494219-28
35
Eye Irrit. 2, H319
(Main constituent)
(Main constituent)
Full text of R-, H- and EUH-phrases: see section 16.
3.2.
Mixtures
Not applicable
Version: 4.0
Revision date: 09-02-2012
page 2 from 12
Safety Data Sheet
according to Regulation (EC) No. 453/2010
Calcium Chloride 35%, aqueous solution
SECTION 4: First aid measures
4.1.
Description of first aid measures
First-aid measures general
: Check the vital functions. Unconscious: maintain adequate airway and respiration.
Respiratory arrest: artificial respiration or oxygen. Cardiac arrest: perform resuscitation.
Victim conscious with laboured breathing: half-seated.
Victim in shock: on his back with legs slightly raised.
Vomiting: prevent asphyxia/aspiration pneumonia.
Prevent cooling by covering the victim (no warming up). Keep watching the victim.
Give psychological aid. Keep the victim calm, avoid physical strain.
Depending on the victim's condition: doctor/hospital.
First-aid measures after inhalation
: The product is only possible to inhale if it is sprayed. Remove the victim into fresh air.
Respiratory problems: consult a doctor/medical service.
First-aid measures after skin contact
: Remove contaminated clothing immediately. Wash immediately with lots of water.
If on skin and if skin irritation or rash occurs, seek medical advice and attention.
Wash contaminated clothing before reuse.
First-aid measures after eye contact
: Immediately flush eyes with plenty of water (> 15min), occasionally lifting the upper and lower
eyelids . Remove contact lenses, if present and easy to do. Continue rinsing.
Seek medical advice.
First-aid measures after ingestion
: Rinse mouth with water. If swallowed, do NOT induce vomiting. If victim conscious and alert, give
1-2 glasses of water to drink. Consult a doctor/medical service if you feel unwell.
Ingestion of large quantities: immediately to hospital.
4.2.
Most important symptoms and effects, both acute and delayed
Symptoms/injuries after inhalation
: Exposure to high concentrations: irritation of the nasal mucous membranes, irritation of the
respiratory tract.
Symptoms/injuries after skin contact
: On continous exposure/contact: slight irritation.
Symptoms/injuries after eye contact
: May cause severe irritation. Symptoms may include: redness of the eye tissue.
Risk of serious permanent damages to eyes if the product is not rapidely removed.
Symptoms/injuries after ingestion
: After absorption of high quantities: irritation of the gastric/intestinal mucosa, nausea, vomiting.
Chronic symptoms
: On continuous/repeated exposure/contact: tingling/irritation of the skin, irritation of the eye tissue,
lacrimation, dry/sore throat.
4.3.
Indication of any immediate medical attention and special treatment needed
Follow the advices in chapter 4.1. Treat symptomatically.
SECTION 5: Firefighting measures
5.1.
Extinguishing media
Suitable extinguishing media
5.2.
Special hazards arising from the substance or mixture
Reactivity
5.3.
: All extinguishing media allowed.
Use fire extinguishing methods suitable to surrounding conditions.
: On heating: release of toxic and corrosive gases/vapours e.g.: (hydrogen chloride).
Reacts violently with (some) compounds.
Reacts slowly with (some) metals: release of highly flammable gases/vapours e.g.: (hydrogen).
This product can react with strong reducing or oxidizing agents.
Advice for firefighters
Precautionary measures fire
: Exposure to fire/heat: keep upwind. Exposure to fire/heat: consider evacuation.
Exposure to heat: seal off low-lying areas.
Exposure to heat: have neighbourhood close doors and windows.
Firefighting instructions
: Dilute toxic gases with water spray.
Protection during firefighting
: Heat/fire exposure: compressed air/oxygen apparatus.
Other information
: Fire-fighters should wear appropriate protective equipment and selfcontained breathing
apparatus (SCBA) with a full face-piece operated in positive pressure mode.
Clothing for fire-fighters (including helmets, protective boots and gloves) conforming to European
standard EN 469 will provide a basic level of protection for chemical incidents.
Version: 4.0
Revision date: 09-02-2012
page 3 from 12
Safety Data Sheet
according to Regulation (EC) No. 453/2010
Calcium Chloride 35%, aqueous solution
SECTION 6: Accidental release measures
6.1.
Personal precautions, protective equipment and emergency procedures
General measures
6.1.1.
: Ensure adequate air ventilation.
For non-emergency personnel
Protective equipment
: Wear protective gloves/protective clothing/eye protection as adviced in section 8.
Emergency procedures
: Mark the danger area. Notify experts. In case of hazardous reactions: keep upwind.
In case of reactivity hazard: consider evacuation.
6.1.2.
For emergency responders
Protective equipment
6.2.
: Wear protective gloves/protective clothing/eye protection as adviced in section 8.
Wear suitable respiratory equipment in case of insufficient ventilation.
Environmental precautions
Prevent uncontrolled discharges into the environment (rivers, water courses, sewers etc.).
See relevant exposure scenarios covering intended use of calcium chloride as de-icing and dust control product.
6.3.
Methods and material for containment and cleaning up
For containment
: Any spillage should be cleaned up immediately.
Collect spill in closed and suitable containers for disposal. Take up rest of liquid spill into
absorbent material sand, earth, vermiculite. Scoop absorbed substance into closing containers.
Methods for cleaning up
: Clean contaminated surfaces with an excess of water.
Wash clothing and equipment after handling.
Other information
: Do not wash out with water in a sensitive environment.
6.4.
Reference to other sections
See section 1 for emergency contact information.
See section 8 for information on appropriate personal protective equipment.
See section 13 for additional waste treatment information.
SECTION 7: Handling and storage
7.1.
Precautions for safe handling
Precautions for safe handling
: Use sufficient ventilation. Avoid breathing dust. Avoid contact with skin and eyes.
Wear protective gloves/protective clothing/eye protection as adviced in section 8.
Care for eyewashstations and security showers at the workplace.
Consult also the relevent exposurescenario in the appendix.
Hygiene measures
: Always wash hands after handling the product. Do not eat, drink or smoke during use.
If on skin, take off contaminated clothing.
7.2.
Conditions for safe storage, including any incompatibilities
Storage conditions
: Store in original container.
Incompatible materials
: Keep away from iron. Do not use with copper/aluminium/zinc - risk of corrosion.
Storage temperature
: -5 till 30 °C
Heat-ignition
: Keep substance away from: heat sources.
Prohibitions on mixed storage
: Keep substancee away from: metals, (strong) acids, oxidizing agents, reducing agents.
Storage area
: Meet the legal requirements. Keep container in a well-ventilated place.
Store at a dry place, at normal room temperature.
Special rules on packaging
: Meet the legal requirements. correctly labelled. closing.
Secure fragile packagings in solid containers.
Packaging materials
: Suitable material: polyethylene. polypropylene.
Material to avoid: metal, stainless steel, aluminium.
7.3.
Specific end use(s)
No specific end uses. See the different exposure scenarios.
Version: 4.0
Revision date: 09-02-2012
page 4 from 12
Safety Data Sheet
according to Regulation (EC) No. 453/2010
Calcium Chloride 35%, aqueous solution
SECTION 8: Exposure controls/personal protection
8.1.
Control parameters
Calciumchloride vloeibaar 35% (10043-52-4)
DNEL/DMEL (Workers)
Acute - local effects, inhalation
Long-term - systemic effects, inhalation
10 mg/m³ (ES8)
No DNEL is derived. No long term effects are expected, also taking into account the
recommended daily intake of 1000 mg/kg bw CaCl2
5 mg/m³ (ES8)
Long-term - local effects, inhalation
DNEL/DMEL (General population)
Acute - local effects, inhalation
Long-term - local effects, inhalation
PNEC (Water)
PNEC aqua (freshwater)
5 mg/m³ (ES10, not included in this SDS)
2,5 mg/m³ (ES10, not included in this SDS)
Because the calcium and chloride concentration varies between aquatic ecosystems (0.06-210
mg/L), it is not considered useful to derive a generic PNEC water or PNEC marine (neither
added or intermittent values)
PNEC (Sediment)
PNEC sediment (freshwater)
No toxicity data on fresh water or marine sediment organisms are available.
Calcium chloride is present in the environment as calcium and chloride ions, which implies that
it will not adsorb on particulate matter. It is not considered useful to derive a PNEC fresh water
or PNEC marine sediment.
PNEC (Soil)
PNEC soil
NEdep 150 g/m2.
If the product is used for de-icing or dust control, see ES7 ( not included in this SDS)
PNEC (Oral)
PNEC oral (secondary poisoning)
In view of the nutritional aspects, the metabolism and the mechanisms of action of calcium and
chloride ions, it is not considered useful to derive a PNEC oral (secondary poisoning)
PNEC (STP)
PNEC sewage treatment plant
8.2.
no toxicity data on sewage treatment plant organisms are available. Because the calcium and
chloride concentration varies between aquatic ecosystems, it is not considered useful to derive
a generic PNEC STP or PNEC STP-added
Exposure controls
Personal protective equipment
:
Hand protection
: Wear gloves (tested to EN374) if hand contamination likely, wash off any skin contamination
immediately.
Material selection gloves
: Good resistance gives:,nitrile rubber,neoprene
Non suitable materials are leather gloves
Take advice to your gloves' supplier
Eye protection
: Use suitable eye protection.
Skin and body protection
: Normal working clothes are suitable.
Respiratory protection
: If this product is handled normally, there is no demand of any respiratory protection.
Environmental exposure controls
: In some cases proces modifications will be necessary to reduce emissions to acceptable levels.
Emissions from ventilation or work process equipment should be checked to ensure they comply
with legislation.
Version: 4.0
Revision date: 09-02-2012
page 5 from 12
Safety Data Sheet
according to Regulation (EC) No. 453/2010
Calcium Chloride 35%, aqueous solution
SECTION 9: Physical and chemical properties
9.1.
Information on basic physical and chemical properties
Physical state
: Liquid
Appearance
: Liquid
Molecular mass
: 110,99 g/mol
Colour
: Colourless
Odour
: Odourless
Odour threshold
: No data available
pH solution
: 7 - 11 (10% w/w)
Crystallization temperature
: -20 °C
Boiling point
: 105 - 125 °C
Flash point
: Not applicable
Flammability (solid, gas)
: No data available
Vapour pressure
: 0,1 Pa
Relative density
: No data available
Density
: 1,35 kg/l
Solubility
: Soluble in water.
Water: completely soluble
Log Pow
: No data available
Self ignition temperature
: Not applicable
Decomposition temperature
: No data available
Viscosity, dynamic
: 0,0058 Pa.s (35% °C)
Explosive properties
: not explosive.
Oxidising properties
: not oxidising.
9.2.
Other information
Minimum ignition energy
: Not applicable
VOC content
: Not applicable
Other properties
: Clear. Physical properties depending on the concentration.
SECTION 10: Stability and reactivity
10.1.
Reactivity
On heating: release of toxic and corrosive gases/vapours e.g.: (hydrogen chloride). Reacts violently with (some) compounds.
Reacts slowly with (some) metals: release of highly flammable gases/vapours e.g.: (hydrogen).
This product can react with strong reducing or oxidizing agents.
10.2.
Chemical stability
Stable under normal conditions.
10.3.
Possibility of hazardous reactions
This product can react with strong reducing or oxidizing agents.
10.4.
Conditions to avoid
Avoid high temperatures. Temperatures lower than -10°C.
Contamination by incompatible materials
10.5.
Incompatible materials
May be corrosive to some metals. This product can cause pitting of and corrosion of some grades of stainless steel.
High temperature and stress conditions can promote stress corrosion cracking.
10.6.
Hazardous decomposition products
Chlorine.
Version: 4.0
Revision date: 09-02-2012
page 6 from 12
Safety Data Sheet
according to Regulation (EC) No. 453/2010
Calcium Chloride 35%, aqueous solution
SECTION 11: Toxicological information
11.1.
Information on toxicological effects
Acute toxicity
Calciumchloride vloeibaar 35% (10043-52-4)
LD50 oral rat
LD50 dermal rat
LC50 inhalation rat (mg/l)
: Not classified
2300 mg/kg
> 5000 mg/kg
> 160 mg/kg
Explanation acute toxicity
The acute toxicity of calcium chloride is low. The combined oral LD50 value in the GLP-compliant study with rat was 2301 mg/kg bw (Toxicological
Laboratories Limited, 1987). The dermal LD50 value in the study with rabbits was above 2000 mg/kg bw (Carreon et al., 1981a). No reliable animal
data are available on the acute inhalation toxicity; however, in accordance with Column 2 of REACH Annex VIII, the study does not need to be
conducted, as sufficient data are available on two other routes of exposure, oral and dermal. In the acute inhalation toxicity study with rats of limited
reliability, signs of irritation of the respiratory tract were described at both exposure levels (40 and 160 mg/m3), suggesting that inhalation of calcium
chloride can cause an irritation of the respiratory tract. As no deaths were observed, LC50 was established to exceed 160 mg/m3.
In addition, Vinnikov et al. (1962) reported treating tuberculosis patients with aerosol inhalations of 2 -5% aqueous calcium chloride. The number of
inhalations varied from below 10 (24 patients), till over 30 (2 patients). Several patients reported irritation of mucos membranes of pharinx and
throat and unpleasant sensation in mouth already after the first inhalations. However, the frequency of such cases was described as minor by the
authors. Overall calcium chloride inhalations were said to have beneficiary effects on disease symptoms (improved quality of spatum, decreased
amounts of spatum, improved ease of spatum expellance, decreased frequency of coughing).
These data are considered to prove that calcium chloride is not acutely toxic by inhalation.
Skin corrosion/irritation
: Not classified
Explanation skin corrosion/irritation
Calcium chloride was found to be not irritating to rabbit skin in the GLP-compliant study, performed according to OECD Guideline 404 (Koopman et
al., 1986e). No effects were noted in any of three rabbits at any observation time points (1, 24, 48 and 72 hours) following an application of the
anhydrous substance under occlusive dressing for 4 hours. However, all long term exposure with water solution with mild irritants could give atopic
dermatitis and skin irritations for sensitive individuals.
Serious eye damage/irritation
: Causes serious eye irritation.
Explanation serious eye damage/irritation
Eye irritation studies are available with anhydrous calcium chloride, calcium chloride dihydrate, calcium chloride hexahydrate and 33% aqueous
solution (Koopman et al., 1986i, 1986j, 1986k, 1986l), performed in accordance with OECD Guideline 405. In each study 100 mg of the material
was instilled in an eye of three rabbits. No rinsing was performed. The results indicate that anhydrous calcium chloride is severely irritating to rabbit
eyes. The cornea and conjunctiva were moderately to severely irritated in all rabbits from one hour till 14 days after treatment. Thereafter the eye of
one rabbit recovered, but there was still a slight haze on the cornea, 21 days after treatment. In the two other rabbits the cornea and conjunctiva
were still moderately irritated 21 days after treatment. The irritating properties of calcium chloride seem to diminish with a higher degree of
hydratation: calcium chloride di- and tetrahydrates are irritating, calcium chloride hexahydrate is moderately irritating.
Respiratory or skin sensitisation
: Not classified
Explanation respiratory or skin sensitisation
Calcium chloride is not sensitizing to skin and respiratory tract. Calcium chloride is considered not to have any sensitising properties, based on the
physiological role of both its constituent ions, as well as the fact that sensitising effects of both ions have never been reported, despite long term
historical and wide dispersive use (e. g. via food and medication). In accordance with section 1`of REACH Annex XI, testing does not appear
scientifically necessary.
Germ cell mutagenicity
: Not classified
Explanation germ cell mutagenicity
Based on the results of two bacterial mutation assays and an in vitro chromosome aberration test in Chinese hamster lung fibroblasts, calcium
chloride is considered not to have a genotoxic potential. Calcium and chloride are normal constituents of the body.
Carcinogenicity
: Not classified
Explanation carcinogenicity
Calcium chloride is not genotoxic in vivo. Calcium and chloride are both essential nutrients for humans and a daily intake of more than 1000 mg for
each of the ions is recommended. Based on this information, it is concluded that that the substance is not carcinogenic.
Version: 4.0
Revision date: 09-02-2012
page 7 from 12
Safety Data Sheet
according to Regulation (EC) No. 453/2010
Calcium Chloride 35%, aqueous solution
SECTION 11: Toxicological information (continue)
Reproductive toxicity
: Not classified
Explanation reproductive toxicity
Effects on fertility: in accordance with section 1 of REACH Annex XI, testing does not appear scientifically necessary, as calcium chloride will
usually not reach the foetus or the male and female reproductive organs when exposed orally, dermally orby inhalation, as it does not become
available systemically. Developmental toxicity: it can be stated that the substance will neither reach the foetus nor reach male and female
reproductive organs (as it does not become systemically available), which shows that there is no risk for developmental toxicity and no risk for
toxicity to reproduction. An oral developmental study was performed in 3 species (mouse, rat and rabbit). In all three species no maternal or
teratogenic effects were noted, and NOAEL 's were above highest dose given.
Specific target organ toxicity (single exposure)
: Not classified
Specific target organ toxicity (repeated
exposure)
: Not classified
Aspiration hazard
: Not classified
Explanation aspiration hazard
Experience of calcium chloride inhalation in humans, Vinnikov et al. (1962): 65 tuberculosis patients (51 males,14 females; age from below 30 till
over 50) were treated with aerosol inhalations of 2 -5% aqueous calcium chloride. The number of inhalations varied from below 10 (24 patients), till
over 30 (2patients). Several patients reported irritation of mucos membranes of pharinx and throat and unpleasant sensation in mouth already after
the first inhalations. However, the frequency of such cases was described as minor by the authors. Overall calcium chloride inhalations were said to
have beneficiary effects on disease symptoms (improved quality of spatum, decreased amounts of spatum, improved ease of spatum expellance,
decreased frequency of coughing). These data are considered to prove that calcium chloride is not acutely toxic by inhalation.
SECTION 12: Ecological information
12.1.
Toxicity
Ecology - general
: Classification concerning the environment: not applicable.
Ecology - air
: Not dangerous for the ozone layer (1999/45/EC).
Ecology - water
: Mild water pollutant (surface water).
For Flanders: maximum concentration in drinking water: 270 mg/l (calcium)(M.B. 28/1/2003).
Maximum concentration in drinking water: 250 mg/l (chloride) (Directive 98/83/EC).
Not harmful to fishes. Slightly harmful to invertebrates (Daphnia). Not harmful to algae.
Calciumchloride vloeibaar 35% (10043-52-4)
LC50 fishes 1
LC50 other aquatic organisms 1
EC50 Daphnia 1
EC50 other aquatic organisms 1
LC50 fishes 2
LC50 other aquatic organisms 2
EC50 Daphnia 2
EC50 other aquatic organisms 2
TLM fishes 1
12.2.
Persistence and degradability
Calciumchloride vloeibaar 35% (10043-52-4)
Persistence and degradability
Biochemical oxygen demand (BOD)
Chemical oyxgen demand (COD)
ThOD
BOD (% of ThOD)
12.3.
13400 mg/l (96 Hours; GAMBUSIA AFFINIS; PURE SUBSTANCE)
759 mg/l (48 Hours; DAPHNIA MAGNA; PURE SUBSTANCE)
144 mg/l (48 Hours; DAPHNIA MAGNA; PURE SUBSTANCE)
4485 mg/l (24 Hours; LYMNAEA SP.; PURE SUBSTANCE)
10650 ppm (96 Hours; LEPOMIS MACROCHIRUS; PURE SUBSTANCE)
580 mg/l (96 Hours; CRUSTACEA; PURE SUBSTANCE)
383 mg/l (48 Hours; DAPHNIA MAGNA; PURE SUBSTANCE)
3130 mg/l (120 Hours; DIATOMEAE; PURE SUBSTANCE)
2400 ppm (48 Hours; PISCES; PURE SUBSTANCE)
Biodegradability: not applicable.
Not applicable
Not applicable
Not applicable
Not applicable
Bioaccumulative potential
Calciumchloride vloeibaar 35% (10043-52-4)
Bioaccumulative potential
Version: 4.0
According to literature, not bioaccumulative.
Revision date: 09-02-2012
page 8 from 12
Safety Data Sheet
according to Regulation (EC) No. 453/2010
Calcium Chloride 35%, aqueous solution
SECTION 12: Ecological information (continue)
12.4.
Mobility in soil
Calciumchloride vloeibaar 35% (10043-52-4)
Mobility in soil
12.5.
Calcium chloride is easily dissociated into calcium and chloride ions. Chloride ions will not
absorb on particulate matter. The calcium ion may bind to soil particulate or may form stable
inorganic salts with sulphate and carbonate ions, but calcium is naturally present in soil.
Results of PBT and vPvB assessment
No additional information available
12.6.
Other adverse effects
No additional information available
SECTION 13: Disposal considerations
13.1.
Waste treatment methods
EURAL code
: 06 03 14 - solid salts and solutions other than those mentioned in 06 03 11 and 06 03 13
Regional legislation (waste)
: Disposal must be done according to official regulations.
Waste treatment methods
: Dispose the product, depending on the degree and type of contamination, either as fertilizer or in
an authorized waste disposal site. Empty and rinsed containers can be disposed as nonhazardous material or be returned for recycling.
Waste disposal recommendations
: Remove waste in accordance with local and/or national regulations. Recycle/reuse.
Additional information
: Hazardous waste (91/689/EEC).
SECTION 14: Transport information
No dangerous good in sense of transport regulations.
SECTION 15: Regulatory information
15.1.
Safety, health and environmental regulations/legislation specific for the substance or mixture
15.1.1.
EU-Regulations
No Annex XVII restrictions
VOC content
: Not applicable
EURAL code
: 06 03 14
15.1.2.
National regulations
No additional information available
15.2.
Chemical safety assessment
A chemical safety assessment has been carried out
Version: 4.0
Revision date: 09-02-2012
page 9 from 12
Safety Data Sheet
according to Regulation (EC) No. 453/2010
Calcium Chloride 35%, aqueous solution
SECTION 16: Other information
Version
: 4.0
Revision date
: 09-02-2012
Date of issue
: 16-04-2004
Supersedes
: 04-08-2011
Indication of changes
: This safety data sheet is fully revised according to the CLP and REACH regulations.
Data sources
: ECHA Website: Information on Registered Substances.
Handbook of Chemistry and Physics CRC Press Inc.
Information from suppliers.
Abbreviations and acronyms
: n.a. = not applicable.
Training advice
: Normal use of this product shall imply use in accordance with the instructions on the packaging.
Before using/handling the product one must read carefully MSDS.
Full text of R-, H- and EUH-phrases:
------ Eye Irrit. 2 Serious eye damage/eye irritation Category 2
------ H319
Causes serious eye irritation
------ R36
Irritating to eyes.
------ Xi
Irritant
------ ERC1
Manufacture of substances
------ ERC2
Formulation of preparations
------ ERC4
Industrial use of processing aids in processes and products, not becoming part of articles
------ ERC6a
Industrial use resulting in manufacture of another substance (use of intermediates)
------ ERC8a
Wide dispersive indoor use of processing aids in open systems
------ ERC8d
Wide dispersive outdoor use of processing aids in open systems
------ PROC1
Use in closed process, no likelihood of exposure
------ PROC10
Roller application or brushing
------ PROC11
Non industrial spraying
------ PROC13
Treatment of articles by dipping and pouring
------ PROC14
Production of preparations or articles by tabletting, compression, extrusion, pelletisation
------ PROC15
Use as laboratory reagent
------ PROC2
Use in closed, continuous process with occasional controlled exposure
------ PROC3
Use in closed batch process (synthesis or formulation)
------ PROC4
Use in batch and other process (synthesis) where opportunity for exposure arises
------ PROC5
Mixing or blending in batch processes for formulation of preparationsand articles (multistage and/or significant contact)
------ PROC6
Calendering operations
------ PROC7
Industrial spraying
------ PROC8a
Transfer of substance or preparation (charging/discharging) from/to vessels/large containers at non-dedicated facilities
------ PROC8b
Transfer of substance or preparation (charging/discharging) from/to vessels/large containers at dedicated facilities
------ PROC9
Transfer of substance or preparation into small containers (dedicated filling line, including weighing)
------ SU22
Professional uses: Public domain (administration, education, entertainment, services, craftsmen)
------ SU3
Industrial uses: Uses of substances as such or in preparations* at industrial sites
Company disclaimer
The information provided in this safety data sheet is correct to the best of our knowledge, information, and belief at the date of its
publication. The information given is designed only as guidance for safe handling, use, processing, storage, transportation,
disposal, and release and is not to be considered a warranty or quality specification. The information relates only to the specific
material designated and may not be valid for such material used in combination with any other materials or in any proceed, unless
specified in the text.
Version: 4.0
Revision date: 09-02-2012
page 10 from 12
Safety Data Sheet
according to Regulation (EC) No. 453/2010
Calcium Chloride 35%, aqueous solution
1. Exposure scenario Nr. 8
ES Ref.: Nr. 8
Handling of (aqueous) Calcium Chloride
solutions ; CAS: 10043-52-4
ES Type: Worker
Version: 1
Revision date: 20-12-2010
Use descriptors
PROC1, PROC2, PROC3, PROC4, PROC5, PROC6, PROC7, PROC8a, PROC8b, PROC9,
PROC10, PROC11, PROC13, PROC14, PROC15
SU0, SU1, SU2a, SU4, SU5, SU6b, SU8, SU9, SU10, SU11, SU12, SU13, SU14, SU15, SU19,
SU20
ERC1, ERC2, ERC4, ERC6a, ERC8a, ERC8d
Processes, tasks, activities covered
Handling of (aqueous) solutions containing Calcium Chloride
Industrial use
Professional use
2. Operational conditions and risk management measures
2.1
Contributing scenario controlling worker exposure
Product characteristics
Physical form of product
Liquid
Concentration of substance in product
Covers percentage substance in the product up to 100 % (unless stated differently)
Vapour pressure
< 0,1 hPa
Liquid, vapour pressure < 10 Pa
Operational conditions
Amounts used
Not applicable
Frequency and duration of use
Covers daily exposures up to 8 hours (unless stated differently)
Human factors not influenced by risk management
Not applicable
Other given operational conditions affecting workers
exposure
Assumes use at not more than 20°C above ambient tem perature, unless stated
differently
Assumes a good basic standard of occupational hygiene is implemented
Risk Management Measures
Technical conditions and measures at process level
(source) to prevent release
Not applicable
Technical conditions and measures to control
dispersion from source towards the worker
No specific measures are necessary.
Organisational measures to prevent /limit releases,
dispersion and exposure
Provide basic employee training to prevent / minimise exposure
Conditions and measures related to personal
protection, hygiene and health evaluation
Avoid all skin contact with product
Clean up contamination/spills as soon as they occur
Wear gloves (tested to EN374) if hand contamination likely, wash off any skin
contamination immediately
Use suitable eye protection
3. Exposure estimation and reference to its source
3.1.
Health
Local - Inhalation
DNEL
Acute: 10 mg/m³
Long-term: 5 mg/m³
Contributing
Scenario
X
3.2.
inhalation exposure acute
(mg/m³)
RCR
Inhalation exposure
long term (mg/m³)
RCR
2
0,2
1
0,2
Assessment method
Environment: -
Version: 4.0
Revision date: 09-02-2012
page 11 from 12
Safety Data Sheet
according to Regulation (EC) No. 453/2010
Calcium Chloride 35%, aqueous solution
4. Guidance to DU to evaluate whether he works inside the boundaries set by the ES
4.1.
Health
Guidance - Health
4.2.
Predicted exposures are not expected to exceed the DN(M)EL when the Risk Management
Measures/Operational Conditions outlined in section 2 are implemented. Where other Risk Management
Measures/Operational Conditions are adopted, then users should ensure that risks are managed to at
least equivalent levels. For more details or further information on the assumptions contained in this
Exposure Scenario, contact the supplier
Environment
Guidance - Environment
Version: 4.0
Not applicable, as for this intended use the substance is not hazardous for the environment
Revision date: 09-02-2012
page 12 from 12